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Abstract
Introduction To assess an optimized 3D imaging protocol
for intracranial nitinol stents in 3D C-arm flat detector
imaging. For this purpose, an image quality simulation and
an in vitro study was carried out.
Methods Nitinol stents of various brands were placed
inside an anthropomorphic head phantom, using iodine
contrast. Experiments with objects were preceded by image
quality and dose simulations. We varied X-ray imaging
parameters in a commercially interventional X-ray system
to set 3D image quality in the contrast–noise–sharpness
space. Beam quality was varied to evaluate contrast of the
stents while keeping absorbed dose below recommended
values. Two detector formats were used, paired with an
appropriate pixel size and X-ray focus size. Zoomed
reconstructions were carried out and snapshot images
acquired. High contrast spatial resolution was assessed
with a CT phantom.
Results We found an optimal protocol for imaging intra-
cranial nitinol stents. Contrast resolution was optimized for
nickel–titanium-containing stents. A high spatial resolution
larger than 2.1 lp/mm allows struts to be visualized. We
obtained images of stents of various brands and a
representative set of images is shown. Independent of the
make, struts can be imaged with virtually continuous
strokes. Measured absorbed doses are shown to be lower
than 50 mGy Computed Tomography Dose Index (CTDI).
Conclusion By balancing the modulation transfer of the
imaging components and tuning the high-contrast imaging
capabilities, we have shown that thin nitinol stent wires can
be reconstructed with high contrast-to-noise ratio and good
detail, while keeping radiation doses within recommended
values. Experimental results compare well with imaging
simulations.
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Introduction
The use of flat detectors allows display of vessel anatomy
with submillimeter resolution and a high contrast-to-noise
ratio (CNR). Three-dimensional (3D) cone beam imaging
using a flat detector in a C-arc system was adopted and
eventually displayed an image quality approaching that of
CT with respect to contrast resolution [1, 2]. However, and
despite the above improvement, 3D imaging of objects with
high X-ray transparency and small detail may still be
difficult [3]. Materials such as nitinol with its excellent
biocompatibility and self deployment by shape memory [4]
are widely used for intracranial stents, and generally yield
good clinical results [5]. The usage of nitinol stents has
become a common practice in the endovascular treatment
as a coiling scaffold [6–8] to prevent wire herniation [9].
The visualization of nitinol stents in treatment of athero-
sclerotic stenoses [10, 11] is challenging and necessitates a
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highly developed X-ray imaging technique. Generally, in
2D clinical imaging protocols, only the stent end-markers
made of tantalum or platinum can be recognized, but the
stent body itself and struts are barely visible due to the low
absorption of the constituents. To improve visualization, we
need a high contrast resolution combined with high spatial
resolution imaging. With 3D cone beam imaging based on
flat detectors, both CNR and spatial resolution can be
tailored such that fine detail rendition is sufficient to
visualize the stent's struts. We describe a vascular imaging
technique validated by an image quality assessment, using
phantom objects with a variety of commercially available
Nitinol stents. The purpose of this study is to visualize
details of a stent, to support an improved analysis of its
placement, by exploiting a joint optimization of all
components of the imaging chain and the associated 3D
vascular imaging platform.
Materials and methods
A proprietary SW package calculates the image quality in
terms of signal flow through the entire imaging chain, using
image quality descriptors like Modulation Transfer Function
(MTF), impulse response, noise power spectrum, low-
contrast and high-contrast (spatial) resolution. Associated
with these descriptors, the acquired dose can be calculated at
any point in the physical chain, including a computed
tomography dose index (CTDI) type of dose assessment for
cone beam imaging. The analytical model also considers all
the intra- and inter-component relations within the imaging
system (also before and after detection). The quality
description also incorporates an image quality degradation
resulting from, e.g., system remnant blurring upon geomet-
rical calibration and arc movement. The analytical model,
comprehensively described by Kroon et al. [12, 13], allows
us to vary the system parameters in X-ray generation,
absorption, dose, and detection as well as in image
processing quality, yielding accurate verified results.
A number of self-expandable nitinol stents (Table 1), as
well as one steel-based stent for reference, were deployed in
plastic (infuse) tubes with an inner diameter of 3.5 mm
which were inserted in a channel of an anthropomorphic
head phantom (CIRS, Norfolk, Virginia; model 603), placed
in the system isocenter. The tubes were filled with a diluted
contrast agent: 500 ml H2O and 50 ml Visip 270 (GE), in
order to produce a 550 HU density mimicking a contrast-
filled vessel. The remainder of the phantom channel was
filled with diluted contrast agent: 5,000 ml H2O and 50 ml
Visip 270, producing 31-HU density. Another set of experi-
ments was carried out by filling the tubes with 31-HU
diluted contrast agent and the remaining volume again with
31 HU, representing blood. Yet, another experiment was
performed by inserting platinum coiling wires close to the
stents, in an air-filled cavity in the phantom, enabling an
assessment of streaking effects.
We used a Philips Xper™ vascular system equipped with
a large (30×40 cm) flat detector and a 3D workstation for
producing the 3D rendered images and hosting the typical
3D image post-processing modules. Images were acquired
with a standard 3D protocol (with 45–49 mGy CTDI dose)
using a large detector zoom format in combination with a
large tube focus, or in a zoomed detector format (22-cm
imaging diagonal) and a small tube focus. A set of 620
images was acquired with a 30 fr/s, resulting in a 20-s scan-
time over a 200-degree arc-travel. CTDI was measured
using a standard measurement protocol with a 16-cm diameter
polymethyl methacrylate (PMMA) cylinder, and dose was
measured with the Unfors (Billdal, Sweden) Mult-O-Meter
601-PMS. The CTDI dose was kept below 50 mGy. We
determined the values using the largest irradiation field
while keeping the technique factors identical to those for
Type Manufacturer Length (mm) Diameter (mm) Strut cross-section (μm) Material
Neuroform Boston Scientific 15 3 w68*t66 Nitinol
Natick, MA
Enterprise Cordis 37 4.5 –a Nitinol
Bridgewater, NJ
Solitaire ev3 20 4 Ø 80 Nitinol
Plymouth, MN
Wingspan Boston Scientific 20 3.5 w68*t73 Nitinol
Natick, MA
Silk Balt Extrusion 25 3.5 –a Nitinol
Montmorency, Fr Four Pt wires
Leo+ Balt Extrusion 25 2.5 –a Nitinol
Montmorency, Fr Two Pt wires
Pharos Micrus/Biotroniks 25 2.75 Ø 60 Steel
San Jose, CA Cr–Co alloy
Table 1 An overview of the
stent properties
a The manufacturers did not supply
the dimensions
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the high-resolution case with its smaller field. The CTDI
protocol would be meaningless for a smaller beam format, as
it is not irradiating the complete cylinder with a diameter of
16 cm, and thus not the peripheral probe positions. Spatial
resolution was measured with a Catphan® 500 phantom (The
Phantom Factory, Salem NY). The resolution reading was
limited by the phantom maximum of 2.1 lp/mm. For the
modeled limiting resolution analysis, a 4% modulation
threshold was chosen. Object (physics governed) contrast
was set by three tube voltages. This led us to the following
protocols: standard 3D neuro protocol (120 kV), intracranial
stent protocol (ics, 80 kV) and ics high resolution (hires,
80 kV, zoomed detector format).
The reconstructions were carried out in a zoomed mode,
i.e., a region of interest was chosen as a fraction of the
maximum volume, determined by the detector size and the
projection geometry. This volume is divided into the
desired voxel matrix. The corresponding technical param-
eters are shown in Table 2, where linear reconstruction
zoom factors of 50% and 33% for the HIRES protocol and
33% and 17% for the standard protocol are listed. A voxel
matrix of 2563 was applied for all cases. The final images
were rendered by maximum intensity projection with a slice
thickness of 5.0 mm, accommodating the stent's radial
dimensions. The zoomed secondary reconstructions were
carried out by panning the volume such that the relevant
stent phantom portions were centered therein.
Results
The high contrast limiting resolution has been optimized by
balancing the relevant MTF of the imaging components,
taking noise transfer into account. Focus size, detector pixel
size, and the reconstruction voxel size are matched such
that the transfer contributions of each parameter are
balanced, resulting in an optimal voxel size and voxel
number. The nearest predefined volume is chosen such that
it matches the size of the stent under test. A further
reduction of the voxel size would increase the image noise,
whereas an increase of the voxel size would result in a
spatial resolution loss. The results on spatial limiting
resolution are shown in Table 3. The true resolution of the
high-resolution protocol is better than the maximum
reading of the Catphan™ 500 phantom and could thus not
be read by this phantom. Deviations of 10–20% between
measured and simulated values were found, which can be
accounted for by the choice of the threshold modulation of
4%. We optimized for the MTF and the inherent system
impulse response, including the stent strut diameter of up to
0.08 mm, as well as for contrast and noise. Since the basic
materials of the stents are identical for all types (see
Table 1), we decided to only use one stent type, namely a
Wingspan nitinol stent. Only in case of the high-resolution/
high-contrast case, the imaging results of all stents are
shown, including the Pharos reference stent.
Reconstructed stent images inside a head phantom
Figures 1, 2, 3, 4, and 5 show snapshots of reconstructed
images in planes through the stent's axes and centered
within the volume, where window settings on the work
station were such that contrast and noise were comparable.
For absolute stent dimensions, see Table 1. Figure 1 shows the
results of the three protocols for 31 HU, where for reference,
an optical image of the stent is shown also. The reconstruc-
tion scaling for the high- and standard resolution cases is
found in Table 2. Figure 2 shows the images for the high
contrast tube filling of 550 HU. Apart from the object
contrast, the conditions are identical to those described for
Fig. 1. The effect of varying the tube voltage is shown in
Fig. 3, referring to a sequence of reconstructed images,
displaying the image contrast for the infuse tubes filled with
31-HU contrast liquid. Figure 4 depicts the effect of streaking
due to highly opaque platinum coils for 31-HU filling.
Finally, in Fig. 5, a number of stent types illustrate the
Spatial resolution Volume definition Measured (lp/mm) Simulated (lp/mm)
Standard Non-zoomed reconstruction volume 0.5 0.5
33% reconstruction volume 1.3 1.6
17% reconstruction volume 1.6 1.8
HIRES Non-zoomed reconstruction volume 1.1 1.2
50% reconstruction volume 2.0 2.5
33% reconstruction volume 2.1a 3.2
Table 3 Limiting high contrast
spatial resolution as measured
with a Catphan® 500 phantom
(The Phantom Factory) and
simulated with the IQ analysis
program
a Catphan® 500 phantom range
limit
Table 2 Volume and voxel dimensions for the standard protocol and







HIRES 50 52.8×52.8×52.8 0.21
33 34.4×34.4×34.4 0.13
Standard 33 82.7×82.7×63.9 0.32
17 42.6×42.6×32.9 0.17
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performance in the high-resolution/high-contrast mode, for
again 31-HU contrast liquid. Figure 5 also shows example
results of the more radiopaque material platinum in the Silk
and Leo stents and the Co–Cr steel alloy-based Pharos stent.
High contrast limiting spatial resolution
Measured and modeled limiting resolutions are summarized
in Table 3. The results on measured resolution were found
by reading the reconstructed images from a Catphan™ 500
phantom in a transaxial plane.
Dose CTDI
By adjusting the technique factors, a CTDI-type weighted
dose is kept at the desired low value of 50 mGy for all
protocols. The actual dose measurement and the analysis
were carried out with a radiation field covering the 16-cm
CTDI phantom. Table 4 shows the measured and
simulated values. The measured intersystem CTDI dose
variability was +/−0.5 mGy. We observed a systematic low
error between measured and analytically modeled dose
values.
Fig. 1 A Wingspan nitinol
stent. A comparison between a
the high-resolution/high-contrast
case, b standard resolution/
high-contrast case, and c the
standard resolution/standard
contrast case. In all cases, an
intra-tube contrast agent of
31 HU was used. The relevant
reconstruction (sub) volumes are
denoted as 50% and 33%
for the HIRES case. For the
standard resolution, 17% and
33% images are shown. For
comparison, a contrast inverted
optical image is shown
on the far left
Fig. 2 A Wingspan nitinol
stent. A comparison between a
the high-resolution/high-contrast
case, b standard resolution/
high-contrast case, and c the
standard resolution/standard
contrast case. In all cases, an
intra-tube high-density contrast
agent of 550 HU was applied.
The relevant reconstruction
(sub) volumes are denoted as
50% and 33% for the
HIRES case. For the standard
resolution, 17% and 33%
images are shown
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Discussion
Intracranial stenting became feasible as a routine treatment
by the introduction of very flexible stents and have become
a single treatment for a number of neurovascular conditions
(Biondi et al. [14], Kurre et al. [15]). The stents are
manufactured from a very thin material and most are self
expanding, i.e., made from an alloy such as nitinol.
However, most nitinol stents are difficult to visualize with
fluoroscopy or C-arm cone beam CT. Visualization can be
improved by increasing the density of the stent, more
radiation, or enhanced image acquisition settings and
processing. Increasing the density will add material and
therefore unfavorably alters the stent characteristics and is
therefore undesirable. An increase in dose will not be
accepted (Struelens et al. [16]). Consequently, the visibility
is preferably improved by further optimizing the imaging
chain. To support and judge correct positioning, the nitinol
stent should be visualized in its wall apposition, while
conforming to varying diameters throughout the stent's
length. To this end, it is advantageous to view details with
virtually optical quality.
During the past 6 years, the image quality of CT-like
reconstructions, using a C-arm interventional X-ray system
equipped with a flat detector, became increasingly notable.
High-resolution imaging, with submillimeter isotropic
spatial resolution, outperformed digital radiography, fluo-
roscopy, and even conventional CT (Kamran et al. [17]). A
continuous effort to enhance image quality enabled imaging
of details with low absorption. Evidence on high-quality in
vitro imaging of the proper deployment of nitinol stents,
related to area coverage, kinking, prolapse, and flattening,
Fig. 3 A Wingspan nitinol
stent. A comparison between
the high-resolution cases
for high-contrast (80 kV) (a),
intermediate contrast (100 kV)
(b), and standard contrast
(120 kV) (c). The 50% and 33%
reconstruction volumes are
shown. The applied intra-tube
density was 31 HU
Fig. 4 Streak artifacts for Pt coils neighboring the Neuroform stent. a High-resolution/high-contrast, b standard resolution/high-contrast case, and
c the standard resolution/standard contrast case
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is given by Aurboonyawat [11], Ebrahimi [18] and
Alvarado [19]. The stent conformity in curved vascular
models and simulated aneurysm necks could be studied in
detail. In a clinical setting, Benndorf [20] showed in vivo
flat panel imaging of the Neuroform nitinol stent. Imagery
of balloon mounted stents, based on a Cr–Co steel alloy,
with intravenous administration of contrast medium, was
carried out by Buhk et al. [21]. The reconstructed images
allowed an accurate assessment of the stented lumen.
Recently, Patel et al. [22] demonstrated high-resolution
and contrast-enhanced simultaneous imaging of intraarterial
cerebrovascular stents and their host arteries.
In our study, a Wingspan stent was chosen as an arbitrary
example object for an evaluation through reconstructed
images. The image quality improvement is assessed by an
evaluation of the reconstructed images. Clearly the spatial
impulse response improved by introducing the HIRES
protocol, as is shown in Fig. 1 for the 31-HU contrast-filled
Fig. 5 High-resolution/
high-contrast cases for 50% and
33% reconstruction
volumes and various stent types.
The tubes were filled with
31-HU contrast. The Enterprise
stent at 33% reconstruction
volume was intentionally left
out due to its large length
not fitting this reduced
volume. The steel-based
Pharos stent was included
for reference
Table 4 Measured and simulated CTDI dose for the standard protocol
and the high-resolution/high-contrast protocol
CTDI Measured dose (mGy) Simulated dose (mGy)
Standard 45 43
HIRES 49 55
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tube, where the CNR was improved as well by the increased
object contrast. These two measures lead to an improved
visibility of the stent's struts, when comparing the standard
protocol (17% zooming) with the results of the high-
resolution/high-contrast protocol (33% zooming). The open
cell structure of the stent is clearly discerned by virtually
continuous strokes of the struts, so that its X-ray quality is
approaching an optical quality. In Fig. 2, a comparison can
be made for the 550-HU contrast filling. In this case, the
contrast between struts and background is lower due to the
denser filling of the tube, giving an accordingly reduced
CNR. The sensitivity to object contrast can be readily
viewed in Fig. 3, where the comparison is made for a
varying tube voltage: the obvious increase in the CNR
makes the stent more pronounced with respect to the (noisy)
background and accounts for the choice of the lowest
voltage, 80 kV, for the ICS and HIRES protocols. In
Fig. 4, streak artifacts associated with high-density platinum
coils are shown. Although the window settings are
optimal for stent perception, details are still rendered
with a sufficient contrast to artifact distance. Finally,
Fig. 5 displays reconstructions of all stent types for the
high-resolution/high-contrast case, showing the detail
rendering of the protocol. As the cross-sections of the
struts of the investigated types vary between 60 and
80 μm, the rendered contrasts vary accordingly, since the
optimized system impulse response dominates for all
cases. The Silk and Leo stents stand out more by high
object contrast of the platinum auxiliary wires. In spite of
the minimal strut diameter, the Pharos struts are rendered
with the highest contrast. The Co–Cr steel alloy accounts
for an increased visibility due to its inherent higher
absorption. The remaining stent types are comparable in
their visualization quality, which is obvious, considering
the similarity in dimensions and composition.
For all protocols under test, the maximum weighted
CTDI dose of 50 mGy is lower than the European
guidelines, as according to EUR 16262 [23]. A dose of
60 mGy is recommended for routine head examinations.
Due to the limited anatomical coverage, by using a smaller
irradiated field in the high-resolution case, the dose-length
product is smaller as well. Moreover, we found that the
difference between modeled and measured doses is suffi-
ciently small.
Conclusions
We have optimized nitinol stent imaging, in the frame-
work of a full-scale 3D imaging model for X-ray
imaging. By balancing the sharpness transfer and noise
transfer of the imaging components and tuning the
contrast-rendering capabilities of a 3D X-ray imaging
system, we showed that thin nitinol stent struts can be
viewed with a high CNR and good detail rendering.
While optimizing, the CTDI radiation doses were kept
below recommended values.
The quality of 3D images, produced with optimum
system settings, proved that independent of the type or
manufacturer of the stents, the detail rendering is adequate
to assess the post-deployment shape. The stent's struts can
be imaged with virtually continuous strokes.
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